$121M later, Langer-backed Selecta raises $70M more from its IPO
Selecta Biosciences ($SELB) landed on Nasdaq with a slight limp, raising $70 million after pricing a bumped-up batch of shares at $14 — the low …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
